Medindia

Surface Logix Appoints Keith Dionne as President and Chief Executive Officer

BOSTON, Oct. 14 Surface Logix, a privately heldbiopharmaceutical company focused on using biophysical chemistry to create anddevelop novel small molecule drugs, is pleased to announce the appointment ...
Business Wire

Nano Terra Acquires Surface Logix, Biomedical Development Firm

BRIGHTON, Mass.--(BUSINESS WIRE)--Nano Terra, Inc., a leading surface engineering and nanotechnology co-development company, today announced it is acquiring Surface Logix, Inc., a drug development ...
FierceBiotech

Surface Logix CEO Resigns

BOSTON, May 15 -- Surface Logix today announced that Jim Mahoney, President & CEO, will be stepping down from his current position to pursue other interests. Mr. Mahoney will maintain a consulting ...
FierceBiotech

Press Release: Surface Logix Raises $20 Million in Second Tranche of Series D Financing

Surface Logix Raises $20 Million in Second Tranche of Series D Financing BOSTON, April 3 -- Surface Logix Inc. announced today that it has closed on $20 million in a second tranche of the Company's ...
Medindia

Surface Logix Announces Executive Management Changes

BOSTON, May 15 Surface Logix today announced that JimMahoney, President & CEO, will be stepping down from his current position topursue other interests. Mr. Mahoney will maintain a consulting ...
The Business Journals

Surface Logix raises $25 million in series C financing

Surface Logix Inc. has announced that it completed a series C round of financing, raising a total of $25 million. New investor HBM BioVentures led the round, joined by others including CalPERS, Intel ...
GEN

Nano Terra and Kadmon Establish JV to Develop Three Drugs and Pharmacomer Platform

Kadmon gets worldwide license to IP recently acquired by Nano Terra from Surface Logix. Kadmon Pharmaceuticals and Nano Terra are establishing a joint venture (JV), NT Life Sciences, to develop three ...
The Business Journals

Surface Logix Inc. sews up $32M private financing

Surface Logix of Boston has closed on $32 million of a $42 million committed private financing, with the $10 million second tranche expected to come in upon the completion of specific milestones.
The Wall Street Transcript

James Mahoney – Surface Logix Inc

JAMES E. MAHONEY is Chief Executive Officer and Director of Surface Logix, Inc. Mr. Mahoney joined Surface Logix in March 2003. Prior to Surface Logix, he was President and Chief Executive Officer of ...
BioWorld

Surface Logix Completes $25M Round For Drug Discovery Work

Medicinal cannabis company Zelira Therapeutics Ltd.’s stock shot up 224% on May 31 on the heels of news that its cannabinoid product, ZLT-L-007, outperformed ...
PE Hub

Surface Logix Raises Series D

Surface Logix Inc., a Brighton, Mass.-based developer of drug optimization programs, has raised $19.9 million in Series D funding, according to a regulatory filing. Return backers include Venrock ...